Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma

Por Treat, Lisa H., McDannold, Nathan, Zhang, Yongzhi, Vykhodtseva, Natalia, Hynynen, Kullervo
Publicado em 2012

Impact of temozolomide on gonadal function in patients with primary malignant brain tumors

Por Strowd, RE, Blackwood, R, Brown, M, Harmon, M, Lovato, J, Yalcinkaya, T, Lesser, G
Publicado em 2013

A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK

Por Dey, Nandini, Williams, Casey, Leyland-Jones, Brain, De, Pradip
Publicado no Am J Transl Res (2015)

Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy

Por Zwingenberger, A.L., Pollard, R.E., Taylor, S.L., Chen, R.X., Nunley, J., Kent, M.S.
Publicado no J Vet Intern Med (2016)

Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy

Por Sanghvi, Samrat M., Lischalk, Jonathan W., Cai, Ling, Collins, Sean, Nair, Mani, Collins, Brain, Unger, Keith
Publicado no Radiat Oncol (2017)

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

Por Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves
Publicado em 2012

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats

Por Liu, Shie-Chau, Alomran, Reem, Chernikova, Sophia B., Lartey, Fred, Stafford, Jason, Jang, Taichang, Merchant, Milton, Zboralski, Dirk, Zöllner, Stefan, Kruschinski, Anna, Klussmann, Sven, Recht, Lawrence, Brown, J. Martin
Publicado em 2014

Tumor treating fields: a novel treatment modality and its use in brain tumors

Por Hottinger, Andreas F., Pacheco, Patricia, Stupp, Roger
Publicado no Neuro Oncol (2016)

Tumors of the central nervous system brain tumors (part 1) /

Por Hayat, M. A.
Publicado em c201

PDCT-06. RADIO-IMMUNOTHERAPY USING THE IDO-INHIBITOR INDOXIMOD IN COMBINATION WITH RE-IRRADIATION FOR CHILDREN WITH PROGRESSIVE BRAIN TUMORS IN THE PHASE 1 SETTING: AN UPDATED REPORT OF SAFETY AND TOLERABILITY...

Por Johnson, Theodore S, Aguilera, Dolly, Al-Basheer, Ahmad, Cooksey, Raven M, Eaton, Bree R, Esiashvili, Natia, Firat, Selim, Fiveash, John B, Foreman, Nicholas, Fridlyand, Diana, Friedman, Gregory K, Giller, Cole A, Grosshans, David R, Heger, Ian M, Kelly, Michael, Kennedy, Eugene P, Knipstein, Jeffrey, Kolhe, Ravindra B, Liu, Arthur K, Martin, William, Mourad, Waleed F, Pacholczyk, Rafal, Parker, Rebecca, Rojiani, Amyn M, Sadek, Ramses F, Thornton, Allan, Vahanian, Nicholas N, MacDonald, Tobey, Munn, David
Publicado no Neuro Oncol (2017)

Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

Por Wagner, Lars M, Adams, Val R
Publicado no Onco Targets Ther (2017)

Genetic alterations of IDH1 and Vegf in brain tumors

Por Veganzones, Silvia, de la Orden, Virginia, Requejo, Lucía, Mediero, Beatriz, González, María Luisa, del Prado, Náyade, Rodríguez García, Carmen, Gutiérrez‐González, Raquel, Pérez‐Zamarrón, Alvaro, Martínez, Armando, Maestro, Marisa L., Zimman, Horacio Mario, González‐Neira, Anna, Vaquero, Jesús, Rodríguez‐Boto, Gregorio
Publicado no Brain Behav (2017)

Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity.

Por Verónica I Landoni, Pablo Schierloh, Marcelo de Campos Nebel, Gabriela C Fernández, Cecilia Calatayud, María J Lapponi, Martín A Isturiz
Publicado em 2012-01-01

Shiga Toxin 1 Induces on Lipopolysaccharide-Treated Astrocytes the Release of Tumor Necrosis Factor-alpha that Alter Brain-Like Endothelium Integrity

Por Landoni, Verónica I., Schierloh, Pablo, de Campos Nebel, Marcelo, Fernández, Gabriela C., Calatayud, Cecilia, Lapponi, María J., Isturiz, Martín A.
Publicado em 2012

IDH1 MUTATIONS AS A IMMUNOTHERAPEUTIC TARGET FOR BRAIN TUMORS

Por Archer, Gary E., Reap, Elizabeth, Norberg, Pam, Cui, Xiuyu, Schmittling, Robert, Herndon, James, Chandramohan, Vidya, Riccione, Katherine, Kuan, Chien-Tsun, Yan, Hai, Bigner, Darell D., Sampson, John H.
Publicado em 2014

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

Por Curtin, James F, Liu, Naiyou, Candolfi, Marianela, Xiong, Weidong, Assi, Hikmat, Yagiz, Kader, Edwards, Matthew R, Michelsen, Kathrin S, Kroeger, Kurt M, Liu, Chunyan, Muhammad, A. K. M. Ghulam, Clark, Mary C, Arditi, Moshe, Comin-Anduix, Begonya, Ribas, Antoni, Lowenstein, Pedro R, Castro, Maria G
Publicado em 2009

Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor...

Por Mansfield, A. S., Aubry, M. C., Moser, J. C., Harrington, S. M., Dronca, R. S., Park, S. S., Dong, H.
Publicado no Ann Oncol (2016)

The Advantage of Bevacizumab in Treating Colorectal Brain Metastasis

Por Hung-Ming Chen, Hao-Wei Teng
Publicado em 2014-09-01

Treatment of Experimental Brain Tumors with Trombospondin-1 Derived Peptides: an In Vivo Imaging Study

Por Bogdanov, A, Marecos, E, Cheng, HC, Chandrasekaran, L, Krutzsch, HC, Roberts, DD, Weissleder, R
Publicado em 1999

Treatment with the NK1 Antagonist Emend Reduces Blood Brain Barrier Dysfunction and Edema Formation in an Experimental Model of Brain Tumors

Por Harford-Wright, Elizabeth, Lewis, Kate M., Ghabriel, Mounir N., Vink, Robert
Publicado em 2014